Steven D Gore Selected Research

Arsenic Trioxide (Trisenox)

5/2015	Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy.
10/2014	New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approach.
2/2011	Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4–7, 2010, Orlando, Florida.
2/2011	Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia.
7/2010	Arsenic trioxide - An old drug rediscovered.
2/2010	Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven D Gore Research Topics

Disease

56	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 04/2002
53	Neoplasms (Cancer) 12/2023 - 04/2002
38	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 04/2002
24	Leukemia 11/2021 - 01/2003
9	Acute Promyelocytic Leukemia 05/2015 - 06/2005
6	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2017 - 06/2011
6	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 12/2005
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 11/2003
5	Refractory Anemia with Excess of Blasts (RAEM) 01/2020 - 04/2010
5	Disease Progression 01/2018 - 08/2010
5	Anemia 06/2017 - 06/2013
4	Thrombosis (Thrombus) 01/2023 - 01/2012
4	Lymphoma (Lymphomas) 11/2018 - 03/2011
3	Refractory Anemia 10/2021 - 08/2010
3	Thrombocytopenia (Thrombopenia) 04/2014 - 03/2010
3	Cytopenia 08/2010 - 12/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023 - 03/2022
2	Polycythemia Vera 01/2023 - 10/2018
2	Essential Thrombocythemia 01/2023 - 01/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 01/2012
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022 - 04/2007
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2019 - 03/2011
2	Mucositis 02/2017 - 06/2005
2	Breast Neoplasms (Breast Cancer) 01/2017 - 08/2007
2	Multiple Myeloma 01/2016 - 07/2010
2	Iron Overload 08/2015 - 12/2009
2	Pathologic Complete Response 11/2012 - 05/2008
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2023
1	Second Primary Neoplasms (Neoplasms, Second) 01/2023
1	Myeloid Sarcoma (Chloroma) 01/2022
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 11/2021
1	COVID-19 11/2021
1	Acute Disease 11/2021
1	Philadelphia Chromosome 11/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2020
1	Bone Marrow Failure Disorders 10/2020

Drug/Important Bio-Agent (IBA)

30	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 03/2009
14	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 06/2005
12	Histone Deacetylase InhibitorsIBA 12/2023 - 10/2005
12	MethyltransferasesIBA 10/2021 - 12/2005
11	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 12/2005
9	entinostat (MS 275)IBA 12/2023 - 10/2005
8	Lenalidomide (CC 5013)FDA Link 10/2021 - 01/2011
8	Decitabine FDA Link 01/2020 - 01/2006
6	AnthracyclinesIBA 01/2020 - 02/2010
6	HematinicsIBA 06/2015 - 01/2012
6	Arsenic Trioxide (Trisenox)FDA Link 05/2015 - 02/2010
6	alvocidib (flavopiridol)IBA 11/2012 - 12/2005
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2014 - 02/2010
5	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2012 - 12/2005
4	IronIBA 08/2015 - 12/2009
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023 - 10/2018
3	Vorinostat FDA Link 08/2017 - 10/2005
3	tipifarnib (R115777)IBA 01/2012 - 05/2008
3	Histone Deacetylases (Histone Deacetylase)IBA 09/2009 - 04/2002
2	Topotecan (Hycamtin)FDA LinkGeneric 10/2023 - 02/2017
2	Clofarabine (Clolar)FDA Link 11/2021 - 09/2007
2	Histones (Histone)IBA 02/2017 - 10/2005
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2017 - 02/2017
2	veliparibIBA 02/2017 - 02/2017
2	Deferasirox FDA Link 08/2015 - 01/2011
2	Etoposide (VP 16)FDA LinkGeneric 01/2012 - 05/2009
2	4-phenylbutyric acid (Buphenyl)FDA Link 06/2006 - 04/2002
1	Apoptosis Regulatory ProteinsIBA 02/2024
1	pembrolizumabIBA 12/2023
1	berzosertibIBA 10/2023
1	Phosphotransferases (Kinase)IBA 10/2023
1	PlatinumIBA 10/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	SM 346IBA 01/2023
1	navitoclaxIBA 03/2022
1	Agent OrangeIBA 01/2022
1	DioxinsIBA 01/2022
1	COVID-19 VaccinesIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Benzene (Benzole)IBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	LubricantsIBA 01/2021
1	LigandsIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	tert-butylserineIBA 10/2020
1	Chimeric Antigen ReceptorsIBA 10/2020
1	Immunoconjugates (Immunoconjugate)IBA 10/2020

Therapy/Procedure

60	Therapeutics 12/2023 - 07/2004
16	Drug Therapy (Chemotherapy) 12/2023 - 11/2004
4	Immunotherapy 12/2023 - 01/2016
4	Consolidation Chemotherapy 05/2015 - 11/2004
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2011 - 01/2003
2	Stem Cell Transplantation 01/2020 - 10/2017
2	Remission Induction 01/2020 - 11/2004
2	Induction Chemotherapy 01/2020 - 01/2018
2	Radiotherapy 01/2017 - 01/2017
2	Chelation Therapy (Therapy, Chelation) 08/2015 - 08/2013
2	Hematopoietic Stem Cell Transplantation 10/2013 - 02/2009
2	Erythrocyte Transfusion 04/2013 - 01/2012
2	Transplantation 04/2013 - 03/2011
2	Duration of Therapy 01/2013 - 06/2005
2	Homologous Transplantation 11/2012 - 09/2011
2	Salvage Therapy 05/2011 - 03/2011
1	Cell Transplantation 10/2020